Verve Therapeutics Inc. – Filings and Transcripts

8-K

Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Other Events, Financial Statements or Exhibits

07/25/25

8-K

Change in Directors, Officers or Compensation

07/15/25

8-K

Lilly to Acquire Verve Therapeutics to Advance One-Time Treatments for People With High Cardiovascular Risk

06/17/25

8-K

Shareholder Vote Results

06/10/25

8-K

Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

05/14/25

8-K

##### ######

04/14/25

8-K

######### ######## ######## ### ####### ###### ####### ### #### #### #### ######### #######

02/27/25

Verve Therapeutics Inc. – Filings and Transcripts

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Verve Therapeutics Inc. – Filings and Transcripts Watch

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Verve Therapeutics Inc. – Filings and Transcripts